HomeIVBIY • OTCMKTS
add
Innovent Biologics ADR Representing 4 Ord Shs
Nakaraang pagsara
$25.42
Sakop ng taon
$19.15 - $25.42
Market cap
90.43B HKD
Average na Volume
21.00
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.73B | 56.07% |
Gastos sa pagpapatakbo | 2.00B | 20.21% |
Net na kita | 148.99M | 133.53% |
Net profit margin | 5.45 | 121.49% |
Kita sa bawat share | — | — |
EBITDA | 136.43M | 136.79% |
Aktuwal na % ng binabayarang buwis | 5.09% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 7.88B | -28.13% |
Kabuuang asset | 21.60B | 4.73% |
Kabuuang sagutin | 8.48B | 4.75% |
Kabuuang equity | 13.12B | — |
Natitirang share | 1.64B | — |
Presyo para makapag-book | 3.17 | — |
Return on assets | 0.90% | — |
Return on capital | 1.22% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 148.99M | 133.53% |
Cash mula sa mga operasyon | 751.33M | 94.97% |
Cash mula sa pag-invest | -305.86M | 64.51% |
Cash mula sa financing | -172.91M | -114.76% |
Net change in cash | 279.70M | -60.42% |
Malayang cash flow | -157.07M | 59.15% |
Tungkol
CEO
Itinatag
Abr 28, 2011
Website
Mga Empleyado
5,659
